A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

In addition, he is currently Coordinating Investigator for a multi-site international industry-sponsored study of the frequency and correlates of impulse control disorders in Parkinson's disease.

A major feature of Parkinson’s disease is the loss of dopamine-producing cells in the brain. As dopamine levels decline, it becomes more difficult for the brain to control movement. ADHD is a ...

Parkinson’s disease (PD) affects nearly 2% of adults over 65, making it the second most common neurodegenerative disorder. It ...

Oct. 10, 2024 — A new technology enables the control ... dopamine in regulating motor function, offering a new therapeutic ... Automatic Speech Recognition Learned to Understand People With ...

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...

A photothermal, nanoparticle-based deep brain stimulation system restored motor skills in mice with Parkinson’s-like disease ...

Nerve cells use a brain chemical called dopamine to help control muscle movement ... fibroblasts in adult humans and Parkinson’s disease patients. Such neurons survived transplantation into ...

A by-product of cholesterol plays a "pivotal" role in Parkinson’s disease ... and eventually trigger the death of dopamine neurons." The new study focused on what causes the spread of ...

Parkinson's Patients Have Improved Motor and Non-Motor Function After Treatment with Theralase(R) Cool Laser TherapyToronto, ...